Floatz logo

Semaglutide

Diastolic Heart Failure

Mayo Clinicprotein_peptidePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Diastolic Heart Failure cohort.

Asset / SponsorPhaseRating
Tirzepatide
Yunlong Wang
Phase 4BBB
Metformin
Sara ElAdawy
Phase 4BBB
Liraglutide
Leiden University Medical Center
Phase 4BBB
Tadalafil
Kafrelsheikh University
Phase 4BB
Febuxostat
National Defense Medical Center, Taiwan
Phase 4BB

View all 23 →

Same molecule, other indications

Semaglutide is also rated in:

metabolic diseaseDormant
A
Indicative ·
81 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →